Literature DB >> 1346370

Modification by ketamine on the neuromuscular actions of magnesium, vecuronium, pancuronium and alpha-bungarotoxin in the primate.

S K Tsai1, K T Liao, C M Lee.   

Abstract

The neuromuscular effects of ketamine, at cumulative doses of 2.5 and 10 mg.kg-1 iv, were studied by electromyographically quantifying the thumb response evoked by ulnar nerve stimulation in 25 monkeys anaesthetized with pentobarbital-N2O-O2. Ketamine alone at these doses had no neuromuscular effects. When the EMG response was maintained at 50% of control by a continuous infusion of magnesium, vecuronium, or pancuronium, ketamine depressed the responses by an additional 13 +/- 3%, 34 +/- 7% and 32.5 +/- 3.3% (mean +/- SEM), respectively, at the highest dose, P less than 0.05. In contrast, ketamine had no effect on the neuromuscular block produced by incremental doses of alpha-bungarotoxin. These results indicate that ketamine does not act on the postjunctional acetylcholine receptor. It plays a secondary role in neuromuscular block, possibly by prejunctional or postjunctional effects independent of receptor occupation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346370     DOI: 10.1007/bf03008679

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  18 in total

1.  Characteristics of nondepolarizing neuromuscular block: (I) post-junctional block by alpha-bungarotoxin.

Authors:  C Lee; D Chen; R L Katz
Journal:  Can Anaesth Soc J       Date:  1977-03

2.  Current status of ketamine anaesthesia.

Authors:  J G Bovill; D L Coppel; J W Dundee; J Moore
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

3.  Ketamine and muscle relaxants.

Authors:  A Wilson
Journal:  Br J Anaesth       Date:  1973-01       Impact factor: 9.166

4.  The interaction of ketamine with d-tubocurarine, pancuronium, and succinylcholine in man.

Authors:  R R Johnston; R D Miller; W L Way
Journal:  Anesth Analg       Date:  1974 Jul-Aug       Impact factor: 5.108

5.  The mechanism and site of action of ketamine on skeletal muscle.

Authors:  M A Maleque; J E Warnick; E X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  1981-12       Impact factor: 4.030

6.  The effect of ketamine upon depolarizing and non-depolarizing neuromuscular blockade in rabbit.

Authors:  L G Bogdan; S N Glisson; A A El-Etr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Ketamine enhances phase I and phase II neuromuscular block of succinylcholine.

Authors:  S K Tsai; C M Lee; B Tran
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

8.  Examination of the mechanisms involved in tetanic fade produced by vecuronium and related analogues in the rat diaphragm.

Authors:  A J Gibb; I G Marshall
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

9.  Pre- and postsynaptic effects of pancuronium at the neuromuscular junction of the mouse.

Authors:  P C Su; W H Su; A D Rosen
Journal:  Anesthesiology       Date:  1979-03       Impact factor: 7.892

10.  Binding of -bungarotoxin to acetylcholine receptors in mammalian muscle (snake venom-denervated muscle-neonatal muscle-rat diaphragm-SDS-polyacrylamide gel electrophoresis).

Authors:  D K Berg; R B Kelly; P B Sargent; P Williamson; Z W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.